Research Updates - Metastatic Breast Cancer

In the following videos, faculty from Dana-Farber Cancer Institute review research updates from the 2022-2023 EMBRACE Metastatic Breast Cancer Patient Forum Series.

Research Update for ER-Positive MBC | 2022-2023 EMBRACE MBC Virtual Forum Series Video

Research Update for ER-Positive MBC | 2022-2023 EMBRACE MBC Virtual Forum Series

Filipa Lynce, MD; Nikhil Wagle, MD; and Lindsay Shaw, AOCNP, ACHPN, discuss advances in research and treatment for patients with ER-positive metastatic breast cancer.
Filipa Lynce, MD

Filipa Lynce, MD

Medical Oncology
Nikhil Wagle, MD

Nikhil Wagle, MD

Medical Oncology
Research Update for HER2-Positive MBC | 2022-2023 EMBRACE MBC Virtual Forum Series Video

Research Update for HER2-Positive MBC | 2022-2023 EMBRACE MBC Virtual Forum Series

Philip Poorvu, MD; Adrienne Waks, MD; and Christine Agius, NP, discuss advances in research and treatment for patients with HER2-positive metastatic breast cancer.
Philip Poorvu, MD Poorvu, MD

Philip Poorvu, MD Poorvu, MD

Instructor in Medicine, Harvard Medical School
Adrienne Waks, MD

Adrienne Waks, MD

Associate Director, Clinical Research
Research Update for Triple Negative MBC | 2021-2022 EMBRACE MBC Virtual Forum Series Video

Research Update for Triple Negative MBC | 2021-2022 EMBRACE MBC Virtual Forum Series

Antonio Giordano, MD, PhD; Sarah Sammons, MD; and Morgan Rutter, MS, BSN, RN, discuss advances in research and treatment for patients with triple negative metastatic breast cancer.
Antonio Giordano, MD Giordano, PhD

Antonio Giordano, MD Giordano, PhD

Assistant Professor of Medicine, Harvard Medical School